<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39464067</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2692-8205</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>14</Day></PubDate></JournalIssue><Title>bioRxiv : the preprint server for biology</Title><ISOAbbreviation>bioRxiv</ISOAbbreviation></Journal><ArticleTitle>Identification and Targeting of Regulators of SARS-CoV-2-Host interactions in the Airway Epithelium.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2024.10.11.617898</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2024.10.11.617898</ELocationID><Abstract><AbstractText>Although the impact of SARS-CoV-2 in the lung has been extensively studied, the molecular regulators and targets of the host-cell programs hijacked by the virus in distinct human airway epithelial cell populations remain poorly understood. This is in part ascribed to the use of non-primary cell systems, overreliance on single-cell gene expression profiling that not ultimately reflect protein activity and bias toward the downstream effects rather than their mechanistic determinants. Here we address these issues by network-based analysis of single cell transcriptomic profiles of pathophysiologically relevant human adult basal, ciliated and secretory cells to identify master regulator (MR) protein modules controlling their SARS-CoV-2-mediated reprogramming. This uncovered chromatin remodeling, endosomal sorting, ubiquitin pathway as well as proviral factors identified by CRISPR analyses as components of the host response collectively or selectively activated in these cells. Large-scale perturbation assays, using a clinically-relevant drug library, identified 11 drugs able to invert the entire MR signature activated by SARS-CoV-2 in these cell types. Leveraging MR analysis and perturbational profiles of human primary cells, represents a novel mechanism-based approach and resource that can be directly generalized to interrogate signatures of other airway conditions for drug prioritization.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dirvin</LastName><ForeName>Brooke</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-3948-1548</Identifier><AffiliationInfo><Affiliation>Columbia Center for Human Development, Columbia University Irving Medical Center, New York, NY USA 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY, USA 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noh</LastName><ForeName>Heeju</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-9299-4852</Identifier><AffiliationInfo><Affiliation>Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY USA 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Systems Biology, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomassoni</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-7720-9166</Identifier><AffiliationInfo><Affiliation>Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY USA 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DarwinHealth Inc., New York, NY USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Danting</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Columbia Center for Human Development, Columbia University Irving Medical Center, New York, NY USA 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Pulmonary Allergy Critical Care, Columbia University Irving Medical Center, New York, NY USA 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yizhou</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Columbia Center for Human Development, Columbia University Irving Medical Center, New York, NY USA 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Pulmonary Allergy Critical Care, Columbia University Irving Medical Center, New York, NY USA 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ke</LastName><ForeName>Xiangye</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Columbia Center for Human Development, Columbia University Irving Medical Center, New York, NY USA 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology, Columbia University Irving Medical Center, New York, NY, USA 1003.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Columbia Center for Human Development, Columbia University Irving Medical Center, New York, NY USA 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Pulmonary Allergy Critical Care, Columbia University Irving Medical Center, New York, NY USA 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schotsaert</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3156-3132</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>García-Sastre</LastName><ForeName>Adolfo</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6551-1827</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karan</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Systems Biology, J.P. Sulzberger Columbia Genome Center, Columbia University Irving Medical Center, New York, NY, USA 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY USA 10032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Califano</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4742-3679</Identifier><AffiliationInfo><Affiliation>Department of Systems Biology, J.P. Sulzberger Columbia Genome Center, Columbia University Irving Medical Center, New York, NY, USA 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY USA 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DarwinHealth Inc., New York, NY USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardoso</LastName><ForeName>Wellington V</ForeName><Initials>WV</Initials><Identifier Source="ORCID">0000-0002-8868-9716</Identifier><AffiliationInfo><Affiliation>Columbia Center for Human Development, Columbia University Irving Medical Center, New York, NY USA 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY, USA 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Pulmonary Allergy Critical Care, Columbia University Irving Medical Center, New York, NY USA 10032.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>bioRxiv</MedlineTA><NlmUniqueID>101680187</NlmUniqueID><ISSNLinking>2692-8205</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">ViroTreat</Keyword><Keyword MajorTopicYN="N">air-liquid-interface</Keyword><Keyword MajorTopicYN="N">airway epithelium</Keyword><Keyword MajorTopicYN="N">drug screening</Keyword><Keyword MajorTopicYN="N">metaVIPER</Keyword><Keyword MajorTopicYN="N">single-cell RNA seq</Keyword><Keyword MajorTopicYN="N">virus-host interactions</Keyword></KeywordList><CoiStatement>DECLARATION OF INTERESTS Dr. Califano is founder, equity holder, and consultant of DarwinHealth Inc., a company that has licensed some of the algorithms used in this manuscript from Columbia University. Columbia niversity is also an equity holder in DarwinHealth Inc. Lorenzo Tomassoni is an employee of DarwinHealth Inc.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>5</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39464067</ArticleId><ArticleId IdType="pmc">PMC11507692</ArticleId><ArticleId IdType="doi">10.1101/2024.10.11.617898</ArticleId><ArticleId IdType="pii">2024.10.11.617898</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hoffmann M. et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181, 271–280 e278 (2020). 10.1016/j.cell.2020.02.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon D. E. et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583, 459–468 (2020). 10.1038/s41586-020-2286-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2286-9</ArticleId><ArticleId IdType="pmc">PMC7431030</ArticleId><ArticleId IdType="pubmed">32353859</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebendenne A. et al. Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs. Nat Genet 54, 1090–1102 (2022). 10.1038/s41588-022-01110-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01110-2</ArticleId><ArticleId IdType="pubmed">35879413</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider W. M. et al. Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks. Cell 184, 120–132 e114 (2021). 10.1016/j.cell.2020.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.12.006</ArticleId><ArticleId IdType="pmc">PMC7796900</ArticleId><ArticleId IdType="pubmed">33382968</ArticleId></ArticleIdList></Reference><Reference><Citation>Triana S. et al. Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut. Mol Syst Biol 17, e10232 (2021). 10.15252/msb.202110232</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.202110232</ArticleId><ArticleId IdType="pmc">PMC8077299</ArticleId><ArticleId IdType="pubmed">33904651</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei J. et al. Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection. Cell 184, 76–91 e13 (2021). 10.1016/j.cell.2020.10.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.028</ArticleId><ArticleId IdType="pmc">PMC7574718</ArticleId><ArticleId IdType="pubmed">33147444</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyler E. et al. Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy. iScience 24, 102151 (2021). 10.1016/j.isci.2021.102151</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102151</ArticleId><ArticleId IdType="pmc">PMC7866843</ArticleId><ArticleId IdType="pubmed">33585804</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y. et al. A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry. Nat Commun 12, 961 (2021). 10.1038/s41467-021-21213-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21213-4</ArticleId><ArticleId IdType="pmc">PMC7878750</ArticleId><ArticleId IdType="pubmed">33574281</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang X. et al. A multi-organoid platform identifies CIART as a key factor for SARS-CoV-2 infection. Nat Cell Biol 25, 381–389 (2023). 10.1038/s41556-023-01095-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-023-01095-y</ArticleId><ArticleId IdType="pmc">PMC10014579</ArticleId><ArticleId IdType="pubmed">36918693</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez M. J. et al. Functional characterization of somatic mutations in cancer using network-based inference of protein activity. Nat Genet 48, 838–847 (2016). 10.1038/ng.3593</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3593</ArticleId><ArticleId IdType="pmc">PMC5040167</ArticleId><ArticleId IdType="pubmed">27322546</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding H. et al. Quantitative assessment of protein activity in orphan tissues and single cells using the metaVIPER algorithm. Nat Commun 9, 1471 (2018). 10.1038/s41467-018-03843-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-03843-3</ArticleId><ArticleId IdType="pmc">PMC5902599</ArticleId><ArticleId IdType="pubmed">29662057</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan S. S. &amp; Kyba M. What is a Master Regulator? J Stem Cell Res Ther 3 (2013). 10.4172/2157-7633.1000e114</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2157-7633.1000e114</ArticleId><ArticleId IdType="pmc">PMC3718559</ArticleId><ArticleId IdType="pubmed">23885309</ArticleId></ArticleIdList></Reference><Reference><Citation>Paull E. O. et al. A modular master regulator landscape controls cancer transcriptional identity. Cell 184, 334–351 e320 (2021). 10.1016/j.cell.2020.11.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.11.045</ArticleId><ArticleId IdType="pmc">PMC8103356</ArticleId><ArticleId IdType="pubmed">33434495</ArticleId></ArticleIdList></Reference><Reference><Citation>Margolin A. A. et al. ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinformatics 7 Suppl 1, S7 (2006). 10.1186/1471-2105-7-S1-S7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-7-S1-S7</ArticleId><ArticleId IdType="pmc">PMC1810318</ArticleId><ArticleId IdType="pubmed">16723010</ArticleId></ArticleIdList></Reference><Reference><Citation>Carro M. S.
et al.
The transcriptional network for mesenchymal transformation of brain tumours. Nature
463, 318–325 (2010). https://doi.org:nature08712
[pii]
10.1038/nature08712
</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08712</ArticleId><ArticleId IdType="pmc">PMC4011561</ArticleId><ArticleId IdType="pubmed">20032975</ArticleId></ArticleIdList></Reference><Reference><Citation>Aytes A. et al. Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy. Cancer Cell 25, 638–651 (2014). 10.1016/j.ccr.2014.03.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccr.2014.03.017</ArticleId><ArticleId IdType="pmc">PMC4051317</ArticleId><ArticleId IdType="pubmed">24823640</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajbhandari P. et al. Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma. Cancer discovery 8, 582–599 (2018). 10.1158/2159-8290.CD-16-0861</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-16-0861</ArticleId><ArticleId IdType="pmc">PMC5967627</ArticleId><ArticleId IdType="pubmed">29510988</ArticleId></ArticleIdList></Reference><Reference><Citation>Mundi P. S. et al. A Transcriptome-Based Precision Oncology Platform for Patient-Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies. Cancer Discov 13, 1386–1407 (2023). 10.1158/2159-8290.CD-22-1020</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-22-1020</ArticleId><ArticleId IdType="pmc">PMC10239356</ArticleId><ArticleId IdType="pubmed">37061969</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez M. J. et al. A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors. Nat Genet 50, 979–989 (2018). 10.1038/s41588-018-0138-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0138-4</ArticleId><ArticleId IdType="pmc">PMC6421579</ArticleId><ArticleId IdType="pubmed">29915428</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeleke T. Z. et al. Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer. Nat Cancer 4, 257–275 (2023). 10.1038/s43018-022-00489-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43018-022-00489-5</ArticleId><ArticleId IdType="pmc">PMC9992270</ArticleId><ArticleId IdType="pubmed">36585452</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamison J. K. et al. Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors. The oncologist (2024). 10.1093/oncolo/oyae118</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oncolo/oyae118</ArticleId><ArticleId IdType="pmc">PMC11379646</ArticleId><ArticleId IdType="pubmed">38886159</ArticleId></ArticleIdList></Reference><Reference><Citation>Arumugam K. et al. The Master Regulator Protein BAZ2B Can Reprogram Human Hematopoietic Lineage-Committed Progenitors into a Multipotent State. Cell Rep 33, 108474 (2020). 10.1016/j.celrep.2020.108474</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108474</ArticleId><ArticleId IdType="pmc">PMC8049840</ArticleId><ArticleId IdType="pubmed">33296649</ArticleId></ArticleIdList></Reference><Reference><Citation>Son J. et al. BACH2 inhibition reverses beta cell failure in type 2 diabetes models. J Clin Invest 131 (2021). 10.1172/JCI153876</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI153876</ArticleId><ArticleId IdType="pmc">PMC8670842</ArticleId><ArticleId IdType="pubmed">34907913</ArticleId></ArticleIdList></Reference><Reference><Citation>Talos F., Mitrofanova A., Bergren S. K., Califano A. &amp; Shen M. M. A computational systems approach identifies synergistic specification genes that facilitate lineage conversion to prostate tissue. Nature communications 8, 14662 (2017). 10.1038/ncomms14662</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14662</ArticleId><ArticleId IdType="pmc">PMC5413950</ArticleId><ArticleId IdType="pubmed">28429718</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra V. et al. Systematic elucidation of neuron-astrocyte interaction in models of amyotrophic lateral sclerosis using multi-modal integrated bioinformatics workflow. Nature communications 11, 5579 (2020). 10.1038/s41467-020-19177-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19177-y</ArticleId><ArticleId IdType="pmc">PMC7642391</ArticleId><ArticleId IdType="pubmed">33149111</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikiz B. et al. The Regulatory Machinery of Neurodegeneration in In Vitro Models of Amyotrophic Lateral Sclerosis. Cell Rep 12, 335–345 (2015). 10.1016/j.celrep.2015.06.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.06.019</ArticleId><ArticleId IdType="pmc">PMC4646662</ArticleId><ArticleId IdType="pubmed">26146077</ArticleId></ArticleIdList></Reference><Reference><Citation>Brichta L. et al. Identification of neurodegenerative factors using translatome-regulatory network analysis. Nat Neurosci 18, 1325–1333 (2015). 10.1038/nn.4070</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4070</ArticleId><ArticleId IdType="pmc">PMC4763340</ArticleId><ArticleId IdType="pubmed">26214373</ArticleId></ArticleIdList></Reference><Reference><Citation>Malagola E. et al. Isthmus progenitor cells contribute to homeostatic cellular turnover and support regeneration following intestinal injury. Cell 187, 3056–3071 e3017 (2024). 10.1016/j.cell.2024.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2024.05.004</ArticleId><ArticleId IdType="pmc">PMC11164536</ArticleId><ArticleId IdType="pubmed">38848678</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa S. et al. The Wnt-dependent master regulator NKX1–2 controls mouse pre-implantation development. Stem cell reports 19, 689–709 (2024). 10.1016/j.stemcr.2024.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2024.04.004</ArticleId><ArticleId IdType="pmc">PMC11103935</ArticleId><ArticleId IdType="pubmed">38701778</ArticleId></ArticleIdList></Reference><Reference><Citation>Laise P. et al. A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral infection. Commun Biol 5, 714 (2022). 10.1038/s42003-022-03663-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-022-03663-8</ArticleId><ArticleId IdType="pmc">PMC9296638</ArticleId><ArticleId IdType="pubmed">35854100</ArticleId></ArticleIdList></Reference><Reference><Citation>Biering S. B. et al. Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection. Nat Genet 54, 1078–1089 (2022). 10.1038/s41588-022-01131-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01131-x</ArticleId><ArticleId IdType="pmc">PMC9355872</ArticleId><ArticleId IdType="pubmed">35879412</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniloski Z. et al. Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells. Cell 184, 92–105 e116 (2021). 10.1016/j.cell.2020.10.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.030</ArticleId><ArticleId IdType="pmc">PMC7584921</ArticleId><ArticleId IdType="pubmed">33147445</ArticleId></ArticleIdList></Reference><Reference><Citation>Aran D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol 20, 163–172 (2019). 10.1038/s41590-018-0276-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-018-0276-y</ArticleId><ArticleId IdType="pmc">PMC6340744</ArticleId><ArticleId IdType="pubmed">30643263</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravindra N. G. et al. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes. PLoS Biol 19, e3001143 (2021). 10.1371/journal.pbio.3001143</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001143</ArticleId><ArticleId IdType="pmc">PMC8007021</ArticleId><ArticleId IdType="pubmed">33730024</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulay A. et al. SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery. Cell Rep 35, 109055 (2021). 10.1016/j.celrep.2021.109055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109055</ArticleId><ArticleId IdType="pmc">PMC8043574</ArticleId><ArticleId IdType="pubmed">33905739</ArticleId></ArticleIdList></Reference><Reference><Citation>Puray-Chavez M. et al. The Translational Landscape of SARS-CoV-2-infected Cells Reveals Suppression of Innate Immune Genes. mBio 13, e0081522 (2022). 10.1128/mbio.00815-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.00815-22</ArticleId><ArticleId IdType="pmc">PMC9239271</ArticleId><ArticleId IdType="pubmed">35604092</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvestri G. A. et al. A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer. N Engl J Med 373, 243–251 (2015). 10.1056/NEJMoa1504601</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1504601</ArticleId><ArticleId IdType="pmc">PMC4838273</ArticleId><ArticleId IdType="pubmed">25981554</ArticleId></ArticleIdList></Reference><Reference><Citation>Team A. S. Shared Gene Expression Alterations in Nasal and Bronchial Epithelium for Lung Cancer Detection. J Natl Cancer Inst 109 (2017). 10.1093/jnci/djw327</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djw327</ArticleId><ArticleId IdType="pmc">PMC6059169</ArticleId><ArticleId IdType="pubmed">28376173</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao S. et al. Long-Term Modeling of SARS-CoV-2 Infection of In Vitro Cultured Polarized Human Airway Epithelium. mBio 11 (2020). 10.1128/mBio.02852-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02852-20</ArticleId><ArticleId IdType="pmc">PMC7649230</ArticleId><ArticleId IdType="pubmed">33158999</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran B. M. et al. Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 Infection. Int J Mol Sci 23 (2022). 10.3390/ijms23020835</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23020835</ArticleId><ArticleId IdType="pmc">PMC8776210</ArticleId><ArticleId IdType="pubmed">35055020</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin S. et al. Analyzing master regulators and scRNA-seq of COVID-19 patients reveals an underlying anti-SARS-CoV-2 mechanism of ZNF proteins. Brief Bioinform 22 (2021). 10.1093/bib/bbab118</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbab118</ArticleId><ArticleId IdType="pmc">PMC8135462</ArticleId><ArticleId IdType="pubmed">33907801</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong H. J., Zhang R., Kuang Y. &amp; Wang X. J. Selective regulation in ribosome biogenesis and protein production for efficient viral translation. Arch Microbiol 203, 1021–1032 (2021). 10.1007/s00203-020-02094-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00203-020-02094-5</ArticleId><ArticleId IdType="pmc">PMC7594972</ArticleId><ArticleId IdType="pubmed">33124672</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X., Liao W. J., Liao J. M., Liao P. &amp; Lu H. Ribosomal proteins: functions beyond the ribosome. J Mol Cell Biol 7, 92–104 (2015). 10.1093/jmcb/mjv014</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjv014</ArticleId><ArticleId IdType="pmc">PMC4481666</ArticleId><ArticleId IdType="pubmed">25735597</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng A. J. L. et al. The nascent polypeptide-associated complex (NAC) controls translation initiation in cis by recruiting nucleolin to the encoding mRNA. Nucleic Acids Res 50, 10110–10122 (2022). 10.1093/nar/gkac751</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac751</ArticleId><ArticleId IdType="pmc">PMC9508830</ArticleId><ArticleId IdType="pubmed">36107769</ArticleId></ArticleIdList></Reference><Reference><Citation>Kretov D. A. et al. YB-1, an abundant core mRNA-binding protein, has the capacity to form an RNA nucleoprotein filament: a structural analysis. Nucleic Acids Res 47, 3127–3141 (2019). 10.1093/nar/gky1303</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1303</ArticleId><ArticleId IdType="pmc">PMC6451097</ArticleId><ArticleId IdType="pubmed">30605522</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu J. H. et al. PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer. Cancer Res 77, 4613–4625 (2017). 10.1158/0008-5472.CAN-17-0216</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-17-0216</ArticleId><ArticleId IdType="pmc">PMC5581676</ArticleId><ArticleId IdType="pubmed">28655788</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C. T. et al. SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming. Cell 186, 112–130 e120 (2023). 10.1016/j.cell.2022.11.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.11.030</ArticleId><ArticleId IdType="pmc">PMC9715480</ArticleId><ArticleId IdType="pubmed">36580912</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang J., Rir-Sim-Ah J. &amp; Tesfaigzi Y. IL-9 and IL-13 induce mucous cell metaplasia that is reduced by IFN-gamma in a Bax-mediated pathway. Am J Respir Cell Mol Biol 38, 310–317 (2008). 10.1165/rcmb.2007-0078OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2007-0078OC</ArticleId><ArticleId IdType="pmc">PMC2258450</ArticleId><ArticleId IdType="pubmed">17901408</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J. et al. Tight junction protein occludin is an internalization factor for SARS-CoV-2 infection and mediates virus cell-to-cell transmission. Proc Natl Acad Sci U S A 120, e2218623120 (2023). 10.1073/pnas.2218623120</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2218623120</ArticleId><ArticleId IdType="pmc">PMC10151465</ArticleId><ArticleId IdType="pubmed">37068248</ArticleId></ArticleIdList></Reference><Reference><Citation>Aminpour M., Hameroff S. &amp; Tuszynski J. A. How COVID-19 Hijacks the Cytoskeleton: Therapeutic Implications. Life (Basel) 12 (2022). 10.3390/life12060814</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12060814</ArticleId><ArticleId IdType="pmc">PMC9225596</ArticleId><ArticleId IdType="pubmed">35743845</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Lu F., Chen Y., Plow E. &amp; Qin J. Integrin mediates cell entry of the SARS-CoV-2 virus independent of cellular receptor ACE2. J Biol Chem 298, 101710 (2022). 10.1016/j.jbc.2022.101710</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2022.101710</ArticleId><ArticleId IdType="pmc">PMC8828381</ArticleId><ArticleId IdType="pubmed">35150743</ArticleId></ArticleIdList></Reference><Reference><Citation>Maginnis M. S. Virus-Receptor Interactions: The Key to Cellular Invasion. J Mol Biol 430, 2590–2611 (2018). 10.1016/j.jmb.2018.06.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2018.06.024</ArticleId><ArticleId IdType="pmc">PMC6083867</ArticleId><ArticleId IdType="pubmed">29924965</ArticleId></ArticleIdList></Reference><Reference><Citation>Simons P. et al. Integrin activation is an essential component of SARS-CoV-2 infection. Sci Rep 11, 20398 (2021). 10.1038/s41598-021-99893-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-99893-7</ArticleId><ArticleId IdType="pmc">PMC8516859</ArticleId><ArticleId IdType="pubmed">34650161</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornung F. et al. Uncovering a unique pathogenic mechanism of SARS-CoV-2 omicron variant: selective induction of cellular senescence. Aging (Albany NY) 15, 13593–13607 (2023). 10.18632/aging.205297</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.205297</ArticleId><ArticleId IdType="pmc">PMC10756098</ArticleId><ArticleId IdType="pubmed">38095608</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones P. L., Sachs L. M., Rouse N., Wade P. A. &amp; Shi Y. B. Multiple N-CoR complexes contain distinct histone deacetylases. J Biol Chem 276, 8807–8811 (2001). 10.1074/jbc.C000879200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C000879200</ArticleId><ArticleId IdType="pubmed">11254656</ArticleId></ArticleIdList></Reference><Reference><Citation>Underhill C., Qutob M. S., Yee S. P. &amp; Torchia J. A novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI/SNF complex and the corepressor KAP-1. J Biol Chem 275, 40463–40470 (2000). 10.1074/jbc.M007864200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M007864200</ArticleId><ArticleId IdType="pubmed">11013263</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R. et al. SARS-CoV-2 Restructures the Host Chromatin Architecture. bioRxiv (2021). 10.1101/2021.07.20.453146</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.20.453146</ArticleId><ArticleId IdType="pmc">PMC10116496</ArticleId><ArticleId IdType="pubmed">36959507</ArticleId></ArticleIdList></Reference><Reference><Citation>West A. C. &amp; Johnstone R. W. New and emerging HDAC inhibitors for cancer treatment. J Clin Invest 124, 30–39 (2014). 10.1172/JCI69738</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI69738</ArticleId><ArticleId IdType="pmc">PMC3871231</ArticleId><ArticleId IdType="pubmed">24382387</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter W. F., Nayak S., Iwasa J. &amp; Taatjes D. J. The Mediator complex as a master regulator of transcription by RNA polymerase II. Nat Rev Mol Cell Biol 23, 732–749 (2022). 10.1038/s41580-022-00498-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-022-00498-3</ArticleId><ArticleId IdType="pmc">PMC9207880</ArticleId><ArticleId IdType="pubmed">35725906</ArticleId></ArticleIdList></Reference><Reference><Citation>Icho S. et al. Dual Inhibition of Vacuolar-ATPase and TMPRSS2 Is Required for Complete Blockade of SARS-CoV-2 Entry into Cells. Antimicrob Agents Chemother 66, e0043922 (2022). 10.1128/aac.00439-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/aac.00439-22</ArticleId><ArticleId IdType="pmc">PMC9295568</ArticleId><ArticleId IdType="pubmed">35703551</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J., Vanstreels E., Jansen S. &amp; Daelemans D. Cellular host factors for SARS-CoV-2 infection. Nat Microbiol 6, 1219–1232 (2021). 10.1038/s41564-021-00958-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-021-00958-0</ArticleId><ArticleId IdType="pubmed">34471255</ArticleId></ArticleIdList></Reference><Reference><Citation>Thankachan J. M. &amp; Setty S. R. G. KIF13A-A Key Regulator of Recycling Endosome Dynamics. Front Cell Dev Biol 10, 877532 (2022). 10.3389/fcell.2022.877532</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.877532</ArticleId><ArticleId IdType="pmc">PMC9081326</ArticleId><ArticleId IdType="pubmed">35547822</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra R. &amp; Banerjea A. C. SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia. Front Immunol 12, 656700 (2021). 10.3389/fimmu.2021.656700</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.656700</ArticleId><ArticleId IdType="pmc">PMC8079643</ArticleId><ArticleId IdType="pubmed">33936086</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y. et al. A Cullin 5-based complex serves as an essential modulator of ORF9b stability in SARS-CoV-2 replication. Signal Transduct Target Ther 9, 159 (2024). 10.1038/s41392-024-01874-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-024-01874-5</ArticleId><ArticleId IdType="pmc">PMC11211426</ArticleId><ArticleId IdType="pubmed">38937432</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B. et al. SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry. Proc Natl Acad Sci U S A 119 (2022). 10.1073/pnas.2117576119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2117576119</ArticleId><ArticleId IdType="pmc">PMC8794821</ArticleId><ArticleId IdType="pubmed">35022217</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei J. et al. Pharmacological disruption of mSWI/SNF complex activity restricts SARS-CoV-2 infection. Nat Genet 55, 471–483 (2023). 10.1038/s41588-023-01307-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-023-01307-z</ArticleId><ArticleId IdType="pmc">PMC10011139</ArticleId><ArticleId IdType="pubmed">36894709</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasciaveo A. et al. OncoLoop: A Network-Based Precision Cancer Medicine Framework. Cancer discovery 13, 386–409 (2023). 10.1158/2159-8290.CD-22-0342</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-22-0342</ArticleId><ArticleId IdType="pmc">PMC9905319</ArticleId><ArticleId IdType="pubmed">36374194</ArticleId></ArticleIdList></Reference><Reference><Citation>Obradovic A. et al. Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulators. Cancer Cell 41, 933–949 e911 (2023). 10.1016/j.ccell.2023.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccell.2023.04.003</ArticleId><ArticleId IdType="pmc">PMC10193511</ArticleId><ArticleId IdType="pubmed">37116491</ArticleId></ArticleIdList></Reference><Reference><Citation>Knox C. et al. DrugBank 6.0: the DrugBank Knowledgebase for 2024. Nucleic Acids Res 52, D1265–D1275 (2024). 10.1093/nar/gkad976</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkad976</ArticleId><ArticleId IdType="pmc">PMC10767804</ArticleId><ArticleId IdType="pubmed">37953279</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K. et al. Clinical HDAC Inhibitors Are Effective Drugs to Prevent the Entry of SARS-CoV2. ACS Pharmacol Transl Sci 3, 1361–1370 (2020). 10.1021/acsptsci.0c00163</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsptsci.0c00163</ArticleId><ArticleId IdType="pmc">PMC7671100</ArticleId><ArticleId IdType="pubmed">34778724</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcos-Villar L., Pazo A. &amp; Nieto A. Influenza Virus and Chromatin: Role of the CHD1 Chromatin Remodeler in the Virus Life Cycle. J Virol 90, 3694–3707 (2016). 10.1128/JVI.00053-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00053-16</ArticleId><ArticleId IdType="pmc">PMC4794673</ArticleId><ArticleId IdType="pubmed">26792750</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha D. P. et al. Targeting GRP78 suppresses oncogenic KRAS protein expression and reduces viability of cancer cells bearing various KRAS mutations. Neoplasia 33, 100837 (2022). 10.1016/j.neo.2022.100837</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neo.2022.100837</ArticleId><ArticleId IdType="pmc">PMC9516447</ArticleId><ArticleId IdType="pubmed">36162331</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaban M. S. et al. Reply to: The stress-inducible ER chaperone GRP78/BiP is upregulated during SARS-CoV-2 infection and acts as a pro-viral protein. Nat Commun 13, 6550 (2022). 10.1038/s41467-022-34066-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34066-2</ArticleId><ArticleId IdType="pmc">PMC9663517</ArticleId><ArticleId IdType="pubmed">36376283</ArticleId></ArticleIdList></Reference><Reference><Citation>Bush E. C. et al. PLATE-Seq for genome-wide regulatory network analysis of high-throughput screens. Nat Commun 8, 105 (2017). 10.1038/s41467-017-00136-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00136-z</ArticleId><ArticleId IdType="pmc">PMC5524642</ArticleId><ArticleId IdType="pubmed">28740083</ArticleId></ArticleIdList></Reference><Reference><Citation>Diacon A. H. et al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N Engl J Med 360, 2397–2405 (2009). 10.1056/NEJMoa0808427</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0808427</ArticleId><ArticleId IdType="pubmed">19494215</ArticleId></ArticleIdList></Reference><Reference><Citation>Milacic M. et al. The Reactome Pathway Knowledgebase 2024. Nucleic Acids Res 52, D672–D678 (2024). 10.1093/nar/gkad1025</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkad1025</ArticleId><ArticleId IdType="pmc">PMC10767911</ArticleId><ArticleId IdType="pubmed">37941124</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Z. et al. Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors. Nature 582, 289–293 (2020). 10.1038/s41586-020-2223-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2223-y</ArticleId><ArticleId IdType="pubmed">32272481</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y. et al. Airway basal cells show regionally distinct potential to undergo metaplastic differentiation. Elife 11 (2022). 10.7554/eLife.80083</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.80083</ArticleId><ArticleId IdType="pmc">PMC9578702</ArticleId><ArticleId IdType="pubmed">36178196</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayers E. W. et al. GenBank. Nucleic Acids Res 49, D92–D96 (2021). 10.1093/nar/gkaa1023</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1023</ArticleId><ArticleId IdType="pmc">PMC7778897</ArticleId><ArticleId IdType="pubmed">33196830</ArticleId></ArticleIdList></Reference><Reference><Citation>Melsted P. et al. Modular, efficient and constant-memory single-cell RNA-seq preprocessing. Nat Biotechnol 39, 813–818 (2021). 10.1038/s41587-021-00870-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-021-00870-2</ArticleId><ArticleId IdType="pubmed">33795888</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachmann A., Giorgi F. M., Lopez G. &amp; Califano A. ARACNe-AP: gene network reverse engineering through adaptive partitioning inference of mutual information. Bioinformatics 32, 2233–2235 (2016). 10.1093/bioinformatics/btw216</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw216</ArticleId><ArticleId IdType="pmc">PMC4937200</ArticleId><ArticleId IdType="pubmed">27153652</ArticleId></ArticleIdList></Reference><Reference><Citation>Irizarry R. A. et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249–264 (2003). 10.1093/biostatistics/4.2.249</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biostatistics/4.2.249</ArticleId><ArticleId IdType="pubmed">12925520</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberzon A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst 1, 417–425 (2015). 10.1016/j.cels.2015.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2015.12.004</ArticleId><ArticleId IdType="pmc">PMC4707969</ArticleId><ArticleId IdType="pubmed">26771021</ArticleId></ArticleIdList></Reference><Reference><Citation>Korotkevich G. et al. (bioRxiv, 2016).</Citation></Reference><Reference><Citation>Bray N. L., Pimentel H., Melsted P. &amp; Pachter L. Near-optimal probabilistic RNA-seq quantification. Nat Biotechnol 34, 525–527 (2016). 10.1038/nbt.3519</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3519</ArticleId><ArticleId IdType="pubmed">27043002</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin F. J. et al. Ensembl 2023. Nucleic Acids Res 51, D933–D941 (2023). 10.1093/nar/gkac958</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac958</ArticleId><ArticleId IdType="pmc">PMC9825606</ArticleId><ArticleId IdType="pubmed">36318249</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G. &amp; He Q. Y. ReactomePA: an R/Bioconductor package for reactome pathway analysis and visualization. Mol Biosyst 12, 477–479 (2016). 10.1039/c5mb00663e</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c5mb00663e</ArticleId><ArticleId IdType="pubmed">26661513</ArticleId></ArticleIdList></Reference><Reference><Citation>Team R. C. (R Foundation for Statistical Computing, Vienna, Austria, 2013).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>